BlackRock, Inc. Reports 9.8% Ownership in Tharimmune Inc.

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 9.8% ownership stake in Tharimmune Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 663,882 shares of Tharimmune's common stock, valued at approximately $1,911,980.16. The shares are held by BlackRock's Reporting Business Units, and the filing includes a certification that the shares were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer. The filing also notes that the interest of one entity, TSP S Fund - Small Cap Stock Index Investment Fund Account, exceeds five percent of the total outstanding common stock.